Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Navarini

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Journal of Experimental Pharmacology|November 25, 2020
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the FutureLuca Navarini, Damiano Currado, Luisa Costa, et al.
Autoimmunity Reviews|January 22, 2021
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?Elvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Plos One|November 8, 2017
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus ErythematosusDomenico Paolo Emanuele Margiotta, Fabio Basta, Giulio Dolcini, et al.
Frontiers in Psychology|October 21, 2024
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases-a cross-sectional studyFrancesco De Vincenzo, Luca Iani, Chiara Alessio, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 18, 2020
Phase angle could be a marker of microvascular damage in systemic sclerosisAntonietta Gigante, Maria Ludovica Gasperini, Edoardo Rosato, et al.
Clinical and Experimental Rheumatology|May 23, 2018
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosisAntonietta Gigante, Domenico Margiotta, Luca Navarini, et al.
Clinical Rheumatology|September 9, 2018
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studySerena Fasano, Domenico Paolo Emanuele Margiotta, Luciana Pierro, et al.
Arthritis Research & Therapy|September 28, 2024
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohortPiero Ruscitti, Damiano Currado, Felice Rivellese, et al.
Autoimmunity Reviews|November 9, 2024
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysisChiara Castellini, Claudia Scotti, Luca Navarini, et al.
Microvascular Research|June 13, 2017
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathyAntonietta Gigante, Luca Navarini, Domenico Margiotta, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Journal of Experimental Pharmacology|November 25, 2020
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the FutureLuca Navarini, Damiano Currado, Luisa Costa, et al.
Autoimmunity Reviews|January 22, 2021
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?Elvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Plos One|November 8, 2017
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus ErythematosusDomenico Paolo Emanuele Margiotta, Fabio Basta, Giulio Dolcini, et al.
Frontiers in Psychology|October 21, 2024
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases-a cross-sectional studyFrancesco De Vincenzo, Luca Iani, Chiara Alessio, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 18, 2020
Phase angle could be a marker of microvascular damage in systemic sclerosisAntonietta Gigante, Maria Ludovica Gasperini, Edoardo Rosato, et al.
Clinical and Experimental Rheumatology|May 23, 2018
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosisAntonietta Gigante, Domenico Margiotta, Luca Navarini, et al.
Clinical Rheumatology|September 9, 2018
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studySerena Fasano, Domenico Paolo Emanuele Margiotta, Luciana Pierro, et al.
Arthritis Research & Therapy|September 28, 2024
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohortPiero Ruscitti, Damiano Currado, Felice Rivellese, et al.
Autoimmunity Reviews|November 9, 2024
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysisChiara Castellini, Claudia Scotti, Luca Navarini, et al.
Microvascular Research|June 13, 2017
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathyAntonietta Gigante, Luca Navarini, Domenico Margiotta, et al.
Pageof 13